Thyroid cancer is generally a slow-progressing disease, and with early diagnosis and appropriate treatment, life expectancy is quite high. Papillary and follicular thyroid cancers are the most common types and usually have a good prognosis. However, in rare aggressive subtypes, the risk may increase.<\/p>\n
The type and stage of the cancer determine life expectancy. Papillary thyroid cancer has a 10-year survival rate of over 95%. In rarer and more aggressive types such as medullary and anaplastic thyroid cancer, this rate decreases significantly. Staging, lymph node involvement, and the presence of metastasis play a critical role.<\/p>\n
Response to treatment directly affects the risk of death. Total thyroidectomy and radioactive iodine therapy are effective in controlling the disease. Treatment success is high in patients diagnosed at an early stage. However, in advanced stages, especially when distant metastasis is present, the risk of mortality may increase.<\/p>\n
Age, gender, and genetic factors are also important. Advanced age, male gender, and certain genetic mutations are associated with a worse course. Regular follow-up of individuals with thyroid cancer is vital in reducing the risk of recurrence and enabling early intervention.<\/p>\n